(Q43031315)

12 November 2017

title

Generation of hepatitis C virus-specific cytotoxic T lymphocytes from healthy individuals with peptide-pulsed dendritic cells (English)

1 reference

12 November 2017

1 reference

Ito A

1

1 reference

12 November 2017

Kanto T

2

1 reference

12 November 2017

Kuzushita N

3

1 reference

12 November 2017

Tatsumi T

4

1 reference

12 November 2017

Sugimoto Y

5

1 reference

12 November 2017

Miyagi T

6

1 reference

12 November 2017

Takehara T

7

1 reference

12 November 2017

Katayama K

8

1 reference

12 November 2017

Mochizuki K

9

1 reference

12 November 2017

Hiramatsu N

10

1 reference

12 November 2017

Kasahara A

11

1 reference

12 November 2017

Yoshiya I

12

1 reference

12 November 2017

Sasaki Y

13

1 reference

12 November 2017

Hori M

14

1 reference

12 November 2017

Hayashi N

15

1 reference

12 November 2017

publication date

1 March 2001

1 reference

Journal of Gastroenterology and Hepatology

12 November 2017

published in

1 reference

12 November 2017

volume

16

1 reference

12 November 2017

issue

3

1 reference

12 November 2017

page(s)

309-316

1 reference

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02383.X

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02383.X

Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02383.X

Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02383.X

Plasmid DNA-based immunization for hepatitis C virus structural proteins: immune responses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02383.X

Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02383.X

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02383.X

Proliferating dendritic cell progenitors in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02383.X

Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02383.X

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02383.X

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02383.X

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02383.X

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02383.X

Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02383.X

HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02383.X

MHC ligands and peptide motifs: first listing

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02383.X

Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02383.X

Induction in vitro of a primary human antiviral cytotoxic T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02383.X

HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02383.X

HLA-A2-binding peptides cross-react not only within the A2 subgroup but also with other HLA-A-locus allelic products

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02383.X

10.1046/J.1440-1746.2001.02383.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference